BloomH. J.: Medroxyprogesterone acetate (Provera) in the treatment of metastatic renal cancer. Brit. J. Cancer, 25; 250 (1971).
3.
BouffiouxC. R.: Epidemiology of renal rumors. Cancer of prostate and kidney, 53; 503 (1981).
4.
BracciU., Di SilverioF.: Attuali orientamenti nella diagnosi e terapia dei carcinomi del rene. Atti Soc. It. Urol., vol. 1, tomo 1, p. 167–194 (1976).
5.
CoxC. E., LacyS. S., MontgomeryW. G., BoyceW. H.: Renal adenocarcinoma: 28-year review, with emphasis on rationale and feasibility of preoperative radiotherapy. J. Urol., 104; 53 (1970).
6.
De KernionJ. B.: Treatment of advanced renal cell carcinoma traditional methods and innovative approaches. J. Urol., 130; 2 (1983).
7.
DonaldsonJ. C., SleaseR. B., DufourD. R., SaltzmanA. R.: Metastatic renal cell carcinoma 24 years after nephrectomy. J.A.M.A., 236; 950 (1976).
8.
FinneyR.: The value of radiotherapy in the treatment of hypernephroma: a clinical trial. Brit. J. Urol., 45; 258 (1973).
9.
FlocksR. H., KadeskyM. C.: Malignant neoplasms of the kidney: an analysis of 353 patients followed 5 years or more. J. Urol., 79; 196 (1958).
10.
FreedS. Z., FeldmanJ. A., SprayragenS.: Follow-up of patients after nephrectomy for renal cell carcinoma. Urology, 9; 500 (1977).
11.
GrabstaldH.: The extent of nephrectomy for renal cell cancer. J.A.M.A., 204; 277 (1968).
12.
GrabstaldH.: Is there a surgical role in managing bone metastases?Intern. J. Radiol. Oncol. Biol. Phys., 1; 1207 (1976).
13.
HursheskyW. J., MurphyG. P.: Current status of the therapy of advanced renal carcinoma. J. Surg. Oncol., 9; 277 (1977).
McDonaldM. W.: Current theraphy for renal cell carcinoma. J. Urol., 127; 211 (1982).
16.
McNicholsD. W., SeguraJ. W., De WeerdJ. H.: Renal carcinoma: long term survival and late recurrence. J. Urol., 126; 17 (1981).
17.
MiddletonR. G.: Surgery for metastatic renal cell carcinoma. J. Urol., 97; 973 (1967).
18.
MontieJ. E., BukowskyR. M., DeodharS. D., HewlettJ. S., StewartB. H., StraffonR. A.: Immunotherapy of disseminated renal cell carcinoma with transfer factor. J. Urol., 117; 553 (1977).
19.
MoralesA., EidingerD.: Bacillus Calmette-Guérin in the treatment of adenocarcinoma of the kidney. J. Urol., 115; 311 (1976).
20.
MurphyG. P., MostofiF. K.: The significance of cytoplasmic granularity in the prognosis of renal cell carcinoma. J. Urol., 94; 48 (1965).
21.
MurphyG. P., MooreR. H., KennyG. M.: Current results from primary and secondary treatment of renal cell carcinoma. J. Urol., 104; 523 (1970).
22.
MurphyG. P.: Proceedings: current results from treatment of renal cell carcinoma. Proc. Nat. Cancer Conf., 7; 751 (1973).
23.
MyersG. H.jr., FehrenbakerL. G., KelalisP. P.: Prognostic significance of renal vein invasion by hypernephroma. J. Urol., 100; 420 (1968).
24.
O'DeaM. J., ZinckeH., UtzD. C., BernatzP. E.: The treatment of renal cell carcinoma with solitary metastasis. J. Urol., 220; 540 (1978).
25.
PizzocaroG.: Hormone therapy and receptor studies in human cell carcinoma. Cancer Prostate & Kidney, 53; 527 (1981).
SatomiY., TakaiS., KondoI., FukushimaS., FuruhataA.: Post operative prophylactic use of progesterone in renal cell carcinoma. J. Urol., 128; 919 (1982).
31.
SchmidtI. D.: Treatment of renal cancer. Cancer Prostate & Kidney, 53; 715 (1981).
32.
SiminovitchJ. P., MontieJ. E., SraffonR. A.: Lymphadenectomy in renal adenocarcinoma. J. Urol., 127; 1090 (1982).
33.
SkinnerD. G., ColvinR. B., VermillionC. D., PfisterR. C., LeadbetterW. F.: Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer, 28; 1165 (1971).
34.
SkinnerD. G., De KernionJ. B., BrowerP. A., RammingK. P., PilchY. H.: Advanced renal cell carcinoma: treatment with xenogenic immune ribonucleic acid and appropriate surgical resection. J. Urol., 115; 246 (1976).
35.
VarkarakisM. G., BhanalaphT., MooreR. H., MurphyG. P.: Prognostic criteria of renal cell carcinoma. J. Surg. Oncol., 6; 97 (1974).
36.
WagleD. G., ScalD. R.: Renal cell carcinoma; a review of 256 cases. J. Surg. Oncol., 2; 23 (1970).
